Entrada Therapeutics Inc

NASDAQ:TRDA   4:00:00 PM EDT
14.97
+0.90 (+6.40%)
5:49:59 PM EDT: $14.97 0.00 (0.00%)
Earnings Announcements

Entrada Therapeutics Reports Q3 Loss Per Share Of $0.80

Published: 11/07/2022 12:59 GMT
Entrada Therapeutics Inc (TRDA) - Entrada Therapeutics Reports Third Quarter 2022 Financial Results.
Entrada Therapeutics Inc- Cash Runway Into 2h 2024 With $216 Million in Cash, Cash Equivalents and Marketable Securities As of September 30, 2022.
Entrada Therapeutics Inc - Qtrly Loss per Share $0.80.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.83

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.90

More details on our Analysts Page.